Claire Harrison - Concepedia

Author

Claire Harrison

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

Anthony Hunter, C Harrison, C N Harrison, C. Harrison, C. N. HARRISON, C. N. Harrison, C.N. Harrison, Claire Harrison, Claire N Harrison, Claire N. Harrison

849

Publications

34.5K

Citations

H-Index

133

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust University of Florence Hôpital Saint-Louis Université Paris Cité The University of Texas MD Anderson Cancer Center

About

Claire Harrison is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	59	5K
2	Health Sciences	15	26	1.9K
3	Engineering	3	3	65
4	Public Health	3	3	67
5	Biostatistics	2	2	57

Claire Harrison

228

Publications

24.4K

Citations

H-Index

Page 1

	Year	Citations
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali, New England Journal of Medicine	2012	1.8K
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i> Jyoti Nangalia, Charles Massie, E. Joanna Baxter, New England Journal of Medicine	2013	1.7K
<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis Linda M. Scott, Wei Tong, Ross L. Levine, New England Journal of Medicine	2007	1.2K
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia Claire Harrison, Peter J. Campbell, Georgina Buck, New England Journal of Medicine	2005	910
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, New England Journal of Medicine	2015	851
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaEuropean LeukemianetPathologyTumor BiologyMyeloid Neoplasia	2011	825
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study Peter J. Campbell, Linda M. Scott, Georgina Buck, The Lancet ThrombopoiesisImmunohematologyThrombosisEssential ThrombocythaemiaHematological Malignancy	2005	643
Classification and Personalized Prognosis in Myeloproliferative Neoplasms Jacob Grinfeld, Jyoti Nangalia, E. Joanna Baxter, New England Journal of Medicine	2018	586
Effect of Mutation Order on Myeloproliferative Neoplasms Christina A. Ortmann, David G. Kent, Jyoti Nangalia, New England Journal of Medicine	2015	559
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis Animesh Pardanani, Claire Harrison, Jörge E. Cortes, JAMA Oncology	2015	453

Page 1